<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02149615</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH 2013-0433 AAMPTC</org_study_id>
    <secondary_id>2013DR4066</secondary_id>
    <nct_id>NCT02149615</nct_id>
  </id_info>
  <brief_title>Antiacne Medications Pseudotumor Cerebri</brief_title>
  <acronym>AAMPTC</acronym>
  <official_title>Prospective Open-label Phase IV Trial to Investigate the Frequency of Optic Disc Swelling, Idiopathic Intracranial Hypertension and Dry Eye Symptoms Under Antiacne Medication Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, ZÃ¼rich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The exact incidence of optic disc swelling and idiopathic intracranial hypertension in
      patients using antiacne medication is not known so far. The investigators hypothesize that
      swelling of retinal nerve fibre layer measured by optical coherence tomography is more
      frequent then assumed so far.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Measurement of retinal nerve fibre layer using optical coherence tomography over a period of
      6 to 9 months depending on exact antiacne medication.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retinal nerve fibre layer</measure>
    <time_frame>9 months</time_frame>
    <description>Measurement of retinal nerve fibre layer using optical coherence tomography. Changes over 10 micrometers are considered to be clinically relevant.
The Term &quot;retinal nerve fibre layer&quot; describes an automated standardized optical coherence tomography measurement program measuring the sectorial thickness of the peripapillar retinal nerve fibre layer. There exists no other term for that.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">310</enrollment>
  <condition>Optic Disc Swelling</condition>
  <arm_group>
    <arm_group_label>isotretinoin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Retinal nerve fibre layer measurement in patients under isotretinoin treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lymecycline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Retinal nerve fibre layer measurement in patients under lymecycline treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>minocycline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Retinal nerve fibre layer measurement in patients under minocycline treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>doxycycline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Retinal nerve fibre layer measurement in patients under doxycycline treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Retinal nerve fibre layer measurement</intervention_name>
    <description>Measurement of retinal nerve fibre layer thickness using optic coherence tomography.</description>
    <arm_group_label>isotretinoin</arm_group_label>
    <arm_group_label>lymecycline</arm_group_label>
    <arm_group_label>minocycline</arm_group_label>
    <arm_group_label>doxycycline</arm_group_label>
    <other_name>effect of medication on optic nerve fibre layer</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Antiacne medication treatment indicated by dermatologist

          -  age &gt; 18 years

          -  contraception if indicated

        Exclusion Criteria:

        - age &lt; 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klara Landau, Prof MD</last_name>
    <role>Study Chair</role>
    <affiliation>UniversityHospital, Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gregor Jaggi, MD</last_name>
    <phone>0041 44 255 49 00</phone>
    <email>gregor.jaggi@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle Meneau</last_name>
    <email>isabelle@meneau@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Meneau</last_name>
      <email>isabelle.meneau@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Gregor Jaggi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.kofam.ch</url>
    <description>Study register Switzerland</description>
  </link>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>May 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2014</study_first_posted>
  <last_update_submitted>May 26, 2014</last_update_submitted>
  <last_update_submitted_qc>May 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>idiopathic intracranial hypertension</keyword>
  <keyword>optic disc swelling</keyword>
  <keyword>antiacne medication</keyword>
  <keyword>isotretinoin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Hypertension</mesh_term>
    <mesh_term>Pseudotumor Cerebri</mesh_term>
    <mesh_term>Papilledema</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Isotretinoin</mesh_term>
    <mesh_term>Lymecycline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

